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ABSTRACT 
Background and Objective: The metabolic syndrome (MetS) increases (P<0.05 for all). The Pearson’s correlation coefficient is positive between 
the risk of cardiovascular diseases and the main aim of this study is to age and MetS (r=0.287, P=0.01). Generally, MetS was common in 37.9% 
explorer prevalence of it in the north of Iran with comparison of Turkman of subjects and it was 14.7% in non-Turkman more than in Turkman people 
and non-Turkman ethnic groups in 2012. Material and Methods: This is a (P=0.015). Prevalence rate of MetS in men and women was 29.7% and 
cross-sectional study that conducted on the 248 subjects aged 25-70 years 43.5%, respectively (P=0.001). Conclusion: In the north of Iran, the preva
(Turkman=88 and non-Turkman=160). Individuals were chosen randomly lence of MetS is high and it was in non-Turkman ethnic group more than in 
from 25 clusters. Waist circumference was measured with the subject Turkman group and in women more than in men while gender differences 
standing at the end of normal breathing; blood pressure was measured only was shown in non-Turkman ethnic group. 
in three times and 5 ml of venous blood drawn after 8-12 h fast in the 
morning for laboratory test. Biochemical analysis including fasting blood Key words: Metabolic Syndrome, Adults, Ethnicity, Iran. 
glucose, triglyceride and high-density lipoprotein (HDL) cholesterol was 
assayed using a commercially kit (Pars Azmoon, Karaj, Iran). ATP-III method Correspondence : 
and SPSS 16.0 software (Chicago II, USA) were used for diagnosis of MetS Mr. Gholamreza Veghari, Ischemic Disorders Research Center, School of  
and for statistical analyzes, respectively. P-value < 0.05 considered statistically Medicine-Golestan University of Medical Sciences, Gorgan-Iran. 
significant. Results: Compare to Turkman group, the mean of FBG (fast
Email: grveghari@yahoo.com ing blood glucose), triglyceride and waist circumference are 15.9 mg/dl, 
30.2 mg/dl and 6.5 cm were more in non-Turkman group, respectively DOI : 10.5530/jcdr.2015.4.1 
INTRODUCTION 
The prevalence of the metabolic syndrome (MetS) has increased over the 
past few years in the world and by 2020, more than 300 million people 
will be affected by the cardiovascular disease risk factors that constitute 
the MetS, glucose intolerance, obesity, hypertension and dyslipidemia. 
The set of criteria to identify MetS are some of cardiometabolic risk 
factors that occur together, including hypertension, hypertriglyceridemia, 
low high-density lipoprotein (HDL) cholesterol, central obesity and 
elevated fasting blood glucose. 
The MetS as a most risk factor increased cardiovascular disease twice as 
much as other agents. The risk associated with MetS is greater than the 
sum of the risks resulting from its component features. MetS is helpful in 
predicting the occurrence of coronary heart disease. 
In recent years, changes in lifestyle and food behaviors extensively resulted 
in increase of cardiovascular disease, diabetes and MetS in worldwide 
especially in developing countries. 
Although several definitions established for MetS but the most practical 
methods are the ATP III (Adult Treatment Panel III) and IDF (Interna­
tional Diabetes Federation). Hence, based on socio-demographic factors 
,ethnicity and type of MetS classification, the prevalence of it may be 
different in population. 
Golestan province located in the north of Iran (South-east of Caspian 
sea) and of 1,7 million people live in this area, 56.1% are in urban area 
and 43.9% are in rural area and whose main job is agriculture. Some 
ethnic groups have been living in the north of Iran as Fars-native, Turkman 
and Sisstani. 
Previous studies reported the hypertension, hypercholesterolemia and 
obesity as the main health problems in the north of Iran as well as cardio­
vascular disease in Iran.Besides, the lifestyle and food behavior differences 
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were seen among ethnic groups that living in this area. Thereby this study 
designed to determine the MetS prevalence in Golestan province (north 
of Iran and south east of Caspian sea) with comparison of Turkman and 
non-Turkman ethnic groups in 2012. 
MATERIAL AND METHODS 
This cross-sectional study has been carried out on the 248 subjects aged 
25-70 years. The required sample size by previous study with estimation 
of 20% MetS rate; a confidence level of 95% and a maximum marginal 
error 0.05, was calculated 246. Subjects were chosen randomly from
25 clusters and each cluster comprised 10 cases in two districts (Kordkoy
and Kalaleh) in Golestan province (north of Iran and south east of
Caspian sea). The clusters were chosen randomly using systematic sampling
technique based on postal code. A trained staff recorded the data during 
three months. Pregnant women and individuals refused to participate 
were excluded in this study. The proportions of Turkman and non-Turkman
ethnic groups are 88(35.5%) and 160(65.5%) cases, respectively. 
Waist circumference (WC)was measured to the nearest 0.5 cm at the
superior border of the iliac crest with the subject standing, at the end of 
normal breathing, blood pressure was measured by a mercury sphygmo­
manometer in three times and 5 ml of venous blood drawn after 8-12 h 
fast in the morning for laboratory test. Biochemical analysis including
fasting blood glucose, triglyceride and HDL-cholesterol was assessed
using a commercially kit (Pars Azmoon, Karaj, Iran). 
The ethnic groups consist of two groups: 1) Turkman: The inter marriage 
of this ethnic group with others was rare and this group can be distin­
guished by phenotype. 2) non-Turkman: Included all of ethnic groups 
(except Turkman) that living in this area. 
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ATP-III method was used for diagnosis of MetS.  According to this
criteria, the presence of at least three of  five the following criteria were 
included as MetS: (1) Abdominal obesity as measured by WC > 102 cm 
in men and >88 cm in women; (2) Triglycerides >150 mg/dl; (3) HDL 
cholesterol <40 mg/dl in men and <50 mg/dl in women; (4) SBP-systolic 
blood pressure ≥130 or DBP-diastolic blood pressure ≥85 mm/Hg; (5) 
fasting plasma glucose ≥110 mg/dl. 
16.0 software (Chicago II, USA) was used for the statistical analysis
using chi-square test and t.test for comparing frequencies and the means, 
respectively. P-value < 0.05 considered statistically significant. This study 
was approved by Ethical Research Committee and consent was received 
from all participants. 
RESULTS 
Mean and standard deviation of MetS components and age based on 
ethnicity and gender were presented in Table 1. Compare to Turkman 
group, the means of FBG (fasting blood glucose), triglyceride and waist 
circumference are 15.9 mg/dl, 30.2 mg/dl and 6.5 cm higher in non-
Turkman group, respectively (P<0.05 for all) while the mean of HDLc in 
Turkman group was significantly 4.9 mg/dl higher than in non-Turkman 
group (P=0.006). HDLc level in women was higher than in men in two 
ethnic groups (P<0.05). The Pearson correlation was shown a positive 
association between age and MetS (r=0.287, P=0.01). 
The prevalence of MetS and its components according to ethnicity were 
presented in Table 2. Generally, the MetS was common in 37.9% of
subjects and it was significantly 14.7% more in non-Turkman than in 
Turkman groups (P=0.015). Prevalence rate of MetS in men and women 
was 29.7% and 43.5% respectively (P=0.001). MetS prevalence differ­
ences was not significant between genders in Turkman group but it was 
significantly more in women than in men in non-Turkman group (31.3% 
vs 51.6%) (P=0.008). The prevalence differences of diabetes mellitus,
hypertension, hypertriglyceridemia, low HDLc and central obesity were 
significant between two ethnic groups. (P<0.05 for all). 
DISCUSSION 
The exact mechanisms of the MetS are under investigation. Its patho­
physiology is very complex and has been only partially explicated.
Sympathetic nervous system overactivity is a key mechanism leading 
to hypertension and increasing obesity has led to a marked increase in 
MetS risk factors. Insulin resistance is strongly associated with excess
triglyceride stores in multiple tissues. 
Based on epidemiologic studies on MetS, a variety o prevalence rate has 
been observed in Iran. The finding of our study has been indicated the 
high prevalence of MetS at 37.9% as whole in the north of Iran, so it 
was more in non-Turkman group (43.1%) more than in Turkman group 
(28.4%) and in women more than in men. 
In a population based study on 3024 Iranian adults aged 25 – 64 years 
from 30 provinces, the age-adjusted prevalence of MetS was about 34.7% 
and in another study, the prevalence of MetS was seen in 33.2% of adults 
in Tehran, according to the ATP III definition. In other parts of Iran, 
MetS was common 23% in Zanjan , 21% (15.4% in men and 24.9% in 
women) in Zahedan and 28.5% (17% in men and 37.8% in women) in 
Semnan. 
Similarly, studies in worldwide, revealed a great variety in the prevalence 
of MetS ranging from 4% in a rural area in Japan to 63.7% in an urban 
area in Pakistan. The prevalence of MetS according to the ATP III in Irish 
population was 13.2%, in urban Pkistan was 49% in adult Qatari was 
33.7% , in Korean adults was 15-30%, in Thailand was 16.6% (18.5% in 
men and 14.7% in women), in Indian American in northern California 
was 33.9% and in Chinese adult population was 24.2% ( 22.1% in men 
and 25.8% in women). 
The prevalence rate of MetS is associated with some of socio-demo­
graphic factors, lifestyle and food behaviors and it was different in world­
wide. The MetS clearly prevalent more in our area compared with some 
regions in Iran and in other countries although the amount was less than 
other parts.The MetS prevalence rate in our area study is in alarming rate 
and a controlling program for it should be established. 
Table 1: Baseline quantitative characteristics of the participants, Mean (standard deviation) 
Characteristics 
Age 
year 
FBG 
mg/dl 
SBP 
mm/hg 
DBP 
mm/hg 
TG 
mg/dl 
HDLc 
mg/dl 
WC 
cm 
Turkman 
Men(34) 45.6(12.8) 91.1(15.5) 126.7(15.7) 79.2(8.9) 126.8(72.7) 49.8(11.9) 89.5(16.1) 
Women(54) 43.1(13.8) 86.7(13.2) 124.0(20.5) 80.1(14.2) 126.7(79.4) 56.9(13.9) 92.1(14.7) 
Total(88) 44.0(13.4) 88.4(14.2) 125.0(18.8) 79.8(12.4) 126.7(76.5) 54.1(13.5) 91.1(15.2) 
P-Value* 0.854 0.153 0.521 0.751 0.995 0.015 0.439 
Non-
Turkman 
Men(67) 
Women(93) 
47.3(14.3) 107.6(50.4) 127.1(18.3) 82.2(11.1) 158.3(103.5) 45.2(11.7) 97.9(12.9) 
47.7(13.6) 101.9(39.4) 131.3(26.5) 84.2(13.5) 156.0(99.8) 52.0(14.3) 97.3(14.6) 
Total(160) 47.6(13.8) 104.3(44.3) 129.5(23.3) 83.4(12.5) 156.9(101.1) 49.2(13.7) 97.6(13.9) 
P-Value* 0.861 0.435 0.265 0.332 0.889 0.002 0.789 
Gender 
Men(101) 46.7(13.8) 102.1(42.7) 81.2(10.5) 126.9(17.4) 147.7(95.0) 46.7(11.9) 95.1(14.6) 
Women(147) 46.0(13.8) 96.3(33.1) 82.7(13.9) 128.6(24.6) 145.3(93.7) 53.8(14.3) 95.4(14.8) 
P-Value** 0.681 0.229 0.386 0.527 0.841 0.001 0.868 
Whole(248) 46.3(13.8) 98.6(37.3) 127.9(21.9) 82.1(12.6) 146.2(94.1) 50.9(13.8) 95.3(14.7) 
P-Value*** 0.052 0.001 0.130 0.032 0.015 0.006 0.001 
* for differences between genders in each of ethnic groups/** for differences between genders as whole; *** for differences between two ethnic groups. 
FBG-fasting blood glucose, SBP-systolic blood pressure, DBP-diastolic blood pressure, TG-triglycerides, HDLc- high-density lipoprotein cholesterol, WC- waist
circumference. 
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Table 2: Prevalence of MetS and components contributed to it based on ethnicity and gender N (%) 
Characteristics 
FBG 
N(%) 
Hypertension 
N(%) 
TG 
N(%) 
HDLc 
N(%) 
Abdominal 
Obesity N(%) 
MetS 
N(%) 
Turkman 
Men(34) 3(8.8) 28(82.4) 12(35.2) 7(20.6) 6(17.6) 9(26.5) 
Women(54) 6(11.1) 31(57.4) 14(25.9) 16(29.6) 28(51.9) 16(29.6) 
Total(88) 9(102.2) 59(67.0) 26(29.5) 23(26.1) 34(38.6) 25(28.4) 
P-Value * 0.516 0.013 0.242 0.247 0.001 0.473 
Non-Turkman 
Men(67) 
Women(93) 
14(20.9) 34(50.7) 30(44.8) 25(37.3) 23(34.3) 21(31.3) 
32(34.4) 49(52.7) 45(48.4) 44(47.3) 69(74.2) 48(51.6) 
Total(160) 46(28.8) 83(51.9) 75(46.9) 69(43.1) 92(57.2) 69(43.1) 
P-Value* 0.045 0.467 0.386 0.136 0.001 0.008 
Gender 
Men(101) 17(16.8) 62(61.4) 42(41.6) 32(31.7) 29(28.7) 30(29.7) 
Women(147) 38(25.9) 80(54.4) 59(40.1) 60(40.8) 97(66.0) 64(43.5) 
P-Value** 0.093 0.276 0.819 0.001 0.001 0.027 
Whole(248) 55(22.2) 142(53.7) 101(40.7) 92(37.1) 126(50.8) 94(37.9) 
P-Value*** 0.001 0.014 0.005 0.006 0.003 0.015 
*for differences between genders in each of ethnic groups/** for differences between genders as whole/*** for differences between two ethnic groups. 
FBG-fasting blood glucose, TG-triglycerides, HDLc-high-density lipoprotein cholesterol, MetS-metabolic syndrome. 
In present study, we found the prevalence of MetS in non-Turkman
group more than in Turkman group. There are some reports that agree
with the impact of ethnicity on MetS components. Africans people have
higher HDLc level compared with Caucasians people.In a epidemiologic
study in rural area in China was found the ethnicity and female gender
as a cardiometabolic risk factor.  The prevalence of obesity and MetS
depends on ethnicity and gender was common more in the Russians
than in the Chuvashes population. In the eastern part of Slovakia, 
the MetS components prevalence were different between Roma and
non-Roma subjects. Previous studies in the north of Iran reported the
obesity in Turkman ethnic group less than in Fars-native subjects. The 
lifestyle and food behaviors between Turkman people and other ethnic
groups are not alike. These differences may be resulted in cardiovas­
cular risk factors varieties among them. Establishing a comprehensive
study is necessary to determine the MetS substantial factors among
ethnic groups in the north of Iran. In line with previous studies in the
literature, MetS was more exhibited in women than in men in our area
study. Despite, significant MetS gender difference was seen in non-
Turkman group, it was not considerable in Turkman group. The gender
prevalence differences partly explained by females’ sedentary life style
compared to males, considering the cultural context in the north of
Iran. On the other hand, men mostly work in outdoor while women
work at home. There is necessary to establish a comprehensive study
to explorer wherefore MetS was not different in gender in Turkman
ethnic group. 
In summary, alarming rate of MetS was seen among northern adults in 
Iran and it was in non-Turkman ethnic group more than in Turkman 
group and in women more than in men. Gender differences were seen 
only in non-Turkman ethnic group. 
We didn’t evaluate food behavior, physical activities, food intake and 
lifestyle. In addition, the sample size was low and we did not provide 
a proper statistical test to consider the design effect caused by cluster 
sampling. They are our limiting study. 
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